stock

was wondering if anyone works for either company or have any details on this merger that was announced ?? what can I expect market wise?

Healthcare giant Johnson & Johnson (JNJ) reported a beat on both the top and bottom line expectations as it posted its Q2 2018 earnings. This was aided by a double-digit growth in Pharmaceutical business and the accelerating sales momentum in the Medical Devices business...

https://news.alphastreet.com/dermira-suffers-a-fatal-fall-after-catastrophic-trial-fail/ Shares of the skin specialist tanked almost 60% on Monday after the company announced that its closely-watched experimental acne drug failed to meet the objectives of two phase 3 clinical trials.

Funny how you are bitching about everything that Novo has done for years but not the great drop in stock

GILD revenue down 13%; profit down 18%; product sales down 14%. Poor sales of hepatitis C drugs with lower sales predicted for the year. Hope the $12 bln acqusition of Kite Pharma should help the company.

https://alphastreet.com/bite/d578727 Amgen, that is in the process of refreshing its product portfolio, reported higher-than-expected 3Q profit, but sales declined in some of its biggest established products.

https://alphastreet.com/bite/d578727 Amgen, that is in the process of refreshing their product portfolios, reported higher-than-expected 3Q profit, but sales declined in some of its biggest established products.

Lower costs and expenses aid in a jump in 3Q17 earnings of Baxter. The company posted net income of $251MM or $0.45 per share, on sales of $2.71Bil. Global sales for Hospital Products grew 7% on continued strength in U.S. fluid systems business as well as favorable demand for injectable...

Since you never went public with my stocks, where's my $1000?